221 related articles for article (PubMed ID: 9721065)
21. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR
Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910
[TBL] [Abstract][Full Text] [Related]
22. Expression of transforming growth factor-beta 1 and growth in soft agar differentiate prostate carcinoma-associated fibroblasts from normal prostate fibroblasts.
San Francisco IF; DeWolf WC; Peehl DM; Olumi AF
Int J Cancer; 2004 Nov; 112(2):213-8. PubMed ID: 15352032
[TBL] [Abstract][Full Text] [Related]
23. Transforming growth factor beta1 stimulates contrasting responses in metastatic versus primary mouse prostate cancer-derived cell lines in vitro.
Sehgal I; Baley PA; Thompson TC
Cancer Res; 1996 Jul; 56(14):3359-65. PubMed ID: 8764134
[TBL] [Abstract][Full Text] [Related]
24. Incidence of apoptosis and cell proliferation in prostate cancer: relationship with TGF-beta1 and bcl-2 expression.
Tu H; Jacobs SC; Borkowski A; Kyprianou N
Int J Cancer; 1996 Oct; 69(5):357-63. PubMed ID: 8900367
[TBL] [Abstract][Full Text] [Related]
25. Inducible expression of transforming growth factor beta1 in papillomas causes rapid metastasis.
Weeks BH; He W; Olson KL; Wang XJ
Cancer Res; 2001 Oct; 61(20):7435-43. PubMed ID: 11606377
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of protein and mRNA expression for transforming growth factor-beta (TGF-beta1) type I and type II receptors in human prostate cancer.
Guo Y; Jacobs SC; Kyprianou N
Int J Cancer; 1997 May; 71(4):573-9. PubMed ID: 9178810
[TBL] [Abstract][Full Text] [Related]
27. Localization of transforming growth factor-beta1 and type II receptor in developing normal human prostate and carcinoma tissues.
Gerdes MJ; Larsen M; McBride L; Dang TD; Lu B; Rowley DR
J Histochem Cytochem; 1998 Mar; 46(3):379-88. PubMed ID: 9487120
[TBL] [Abstract][Full Text] [Related]
28. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
Guo Y; Kyprianou N
Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
[TBL] [Abstract][Full Text] [Related]
29. The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer.
Kattan MW; Shariat SF; Andrews B; Zhu K; Canto E; Matsumoto K; Muramoto M; Scardino PT; Ohori M; Wheeler TM; Slawin KM
J Clin Oncol; 2003 Oct; 21(19):3573-9. PubMed ID: 12913106
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
Guo Y; Kyprianou N
Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
[TBL] [Abstract][Full Text] [Related]
31. Role of transforming growth factor-beta 1 in invasion and metastasis in gastric carcinoma.
Maehara Y; Kakeji Y; Kabashima A; Emi Y; Watanabe A; Akazawa K; Baba H; Kohnoe S; Sugimachi K
J Clin Oncol; 1999 Feb; 17(2):607-14. PubMed ID: 10080606
[TBL] [Abstract][Full Text] [Related]
32. TGF-β Effects on Prostate Cancer Cell Migration and Invasion Require FosB.
Barrett CS; Millena AC; Khan SA
Prostate; 2017 Jan; 77(1):72-81. PubMed ID: 27604827
[TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor beta as a clinical biomarker for prostate cancer.
Perry KT; Anthony CT; Case T; Steiner MS
Urology; 1997 Jan; 49(1):151-5. PubMed ID: 9000208
[TBL] [Abstract][Full Text] [Related]
34. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone.
Masi L; Malentacchi C; Campanacci D; Franchi A
Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923
[TBL] [Abstract][Full Text] [Related]
35. Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis.
Han G; Lu SL; Li AG; He W; Corless CL; Kulesz-Martin M; Wang XJ
J Clin Invest; 2005 Jul; 115(7):1714-23. PubMed ID: 15937546
[TBL] [Abstract][Full Text] [Related]
36. Loss of expression of transforming growth factor beta type I and type II receptors correlates with tumor grade in human prostate cancer tissues.
Kim IY; Ahn HJ; Zelner DJ; Shaw JW; Lang S; Kato M; Oefelein MG; Miyazono K; Nemeth JA; Kozlowski JM; Lee C
Clin Cancer Res; 1996 Aug; 2(8):1255-61. PubMed ID: 9816295
[TBL] [Abstract][Full Text] [Related]
37. Predictive value of expression of transforming growth factor-beta(1) and its receptors in transitional cell carcinoma of the urinary bladder.
Kim JH; Shariat SF; Kim IY; Menesses-Diaz A; Tokunaga H; Wheeler TM; Lerner SP
Cancer; 2001 Sep; 92(6):1475-83. PubMed ID: 11745225
[TBL] [Abstract][Full Text] [Related]
38. Mammalian target of rapamycin and 3-phosphatidylinositol 3-kinase pathway inhibition enhances growth inhibition of transforming growth factor-beta1 in prostate cancer cells.
van der Poel HG
J Urol; 2004 Oct; 172(4 Pt 1):1333-7. PubMed ID: 15371835
[TBL] [Abstract][Full Text] [Related]
39. Antiproliferative effect of a vitamin D3 analog, EB1089, on HL-60 cells by the induction of TGF-beta receptor.
Jung CW; Kim ES; Seol JG; Park WH; Lee SJ; Kim BK; Lee YY
Leuk Res; 1999 Dec; 23(12):1105-12. PubMed ID: 10613355
[TBL] [Abstract][Full Text] [Related]
40. Concordant upregulation of type II-TGF-beta-receptor, the cyclin-dependent kinases inhibitor P27Kip1 and cyclin E in human atherosclerotic tissue: implications for lesion cellularity.
Ihling C; Technau K; Gross V; Schulte-Mönting J; Zeiher AM; Schaefer HE
Atherosclerosis; 1999 May; 144(1):7-14. PubMed ID: 10381272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]